Browse by author
Lookup NU author(s): Dr Daniel OkeowoORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
AbstractIntroductionStopping medicines where harms outweigh benefits (deprescribing) (1) can reduce adverse events from inappropriate polypharmacy. Deprescribing should be undertaken in a patient-centred way with shared decision-making. However, there is a lack of evidence about the patient perspective on how deprescribing should be safely and routinely implemented in UK primary care. Such evidence is needed to enhance the implementation of deprescribing in primary care.Aim• To identify optimal methods of introducing and actioning deprescribing from the patient’s perspective• To understand the nature of support patients require during deprescribing• To identify patient views on the involvement of different healthcare professionals in deprescribing.MethodsUK patients aged ≥65 years taking ≥5 medicines and living in their own homes were recruited through social media, service user groups and NIHR People in Research. An interview guide was developed using deprescribing literature, patient and public involvement input, and informed by the theoretical implementation framework Normalisation Process Theory (2). Interviews were conducted online (Microsoft Teams®) or via telephone, audio recorded and transcribed verbatim. Data were analysed using the Framework method.ResultsTwenty patients, diverse in age and gender, were recruited and three main themes developed: 1. ‘Why deprescribe now?’ focused on the importance of communicating the deprescribing rationale; 2. ‘Monitoring and follow-up’ in which safety netting around deprescribing and patients’ motivations to self-monitor after deprescribing interventions were highlighted; 3. ‘Roles and relationships’ focused on patient views of different healthcare professionals involved in deprescribing and the interpersonal skills needed to develop therapeutic relationships.ConclusionOptimal methods of introducing deprescribing from the patient’s perspective included communication of a convincing and well-communicated rationale for stopping medicines. Patients required support from a range of healthcare professionals with whom they had an existing therapeutic relationship. Whilst patients were motivated to self-monitor any unwanted/unexpected effects post-deprescribing, this was under the condition that timely support would be available when needed. These findings provide a deeper understanding of patients’ needs for the implementation of safe and routine deprescribing in primary care, and these should be considered when designing medication review and deprescribing services. A strength of this study was the overall diversity in age and gender of the patients interviewed. However, although multiple recruitment pathways were utilised, due to the COVID-19 pandemic, recruitment was mainly online which will have excluded patients who did not have access to the internet.
Author(s): Okeowo Daniel, Fylan Beth, Quyyam Faiqah, Butt Nazreen, Mills Tom, Zaidi Tabish, Alldred David
Publication type: Conference Proceedings (inc. Abstract)
Publication status: Published
Conference Name: Health Services Research and Pharmacy Practice Conference : Advancing Sustainable Medicines Optimisation
Year of Conference: 2023
Pages: i36-i36
Print publication date: 01/04/2023
Online publication date: 13/04/2023
Acceptance date: 13/04/2023
ISSN: 0961-7671
Publisher: Oxford University Press
URL: https://doi.org/10.1093/ijpp/riad021.042
DOI: 10.1093/ijpp/riad021.042
Series Title: International Journal of Pharmacy Practice
